000902559 001__ 902559
000902559 005__ 20220114140057.0
000902559 0247_ $$2Handle$$a2128/30107
000902559 037__ $$aFZJ-2021-04358
000902559 088__ $$2Other$$a4430
000902559 1001_ $$0P:(DE-Juel1)165360$$aEvcüman, Sibel$$b0$$eCorresponding author$$ufzj
000902559 245__ $$aSynthese 18F-markierter PET-Tracer durch nukleophile Kupfer-vermittelte Radiofluorierung$$f- 2021-07-21
000902559 260__ $$aJülich$$bForschungszentrum Jülich GmbH Zentralbibliothek, Verlag$$c2021
000902559 300__ $$aVII,  187
000902559 3367_ $$2DataCite$$aOutput Types/Dissertation
000902559 3367_ $$0PUB:(DE-HGF)3$$2PUB:(DE-HGF)$$aBook$$mbook
000902559 3367_ $$2ORCID$$aDISSERTATION
000902559 3367_ $$2BibTeX$$aPHDTHESIS
000902559 3367_ $$02$$2EndNote$$aThesis
000902559 3367_ $$0PUB:(DE-HGF)11$$2PUB:(DE-HGF)$$aDissertation / PhD Thesis$$bphd$$mphd$$s1641912287_22042
000902559 3367_ $$2DRIVER$$adoctoralThesis
000902559 4900_ $$aBerichte des Forschungszentrums Jülich$$v4430
000902559 502__ $$aDissertation, Univ. Köln, 2021$$bDissertation$$cUniv. Köln$$d2021
000902559 520__ $$aPositron emission tomography (PET) enables to detect physiological and pathophysiological processeson the cellular or molecular level. Therefore, PET has gained great importance as a diagnostic imagingtechnique. Thus, a number of neurological and neoplastic disordes are associated with alterations inthe expression or activity of certain receptors, transporters or enzymes, which can be visualized andquantified using PET imaging. This is achieved by the application of radiolabeled probes (tracers) thatselectively interact with a molecular target of interest and can be detected non-invasively based onthe emission of positrons. Owing to its favorable half-live and the low energy of emitted positrons,fluorine-18 is one of the most attractive radionuclides for labeling of PET-tracers. A number of noveltransition metal-mediated, late-stage radiofluorination methods have enabled an easy access to 18Flabeledaromatic systems regardless of their electronic properties. In particular, Cu-mediatedradiofluorination with alcohols as co-solvents has been shown to afford high radiochemical yields(RCYs) of several clinically relevant PET tracers that are hardly or not accessible by conventionalmethods.The aim of the present work was to prepare 18F-labeled PET tracers for different molecular targets byalcohol-enhanced Cu-mediated radiofluorination and to evaluate their properties by preclinicalexperiments in vitro and in vivo. The molecular targets were selected based on their pathophysiologicalrelevance and comprised the glycine transporter 1 (GlyT1), the synaptic vesicle glycoprotein 2A (SV2A)and the A1 adenosine receptor (A1AR). Following identification of suitable high-affinity lead structures,the corresponding precursor compounds were synthesized and subsequently radiolabeled usingcopper-mediated radiofluorination.
000902559 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000902559 8564_ $$uhttps://juser.fz-juelich.de/record/902559/files/J%C3%BCl_4430.pdf$$yOpenAccess
000902559 909CO $$ooai:juser.fz-juelich.de:902559$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000902559 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000902559 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000902559 9141_ $$y2021
000902559 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)165360$$aForschungszentrum Jülich$$b0$$kFZJ
000902559 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000902559 920__ $$lyes
000902559 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000902559 980__ $$aphd
000902559 980__ $$aVDB
000902559 980__ $$aUNRESTRICTED
000902559 980__ $$abook
000902559 980__ $$aI:(DE-Juel1)INM-5-20090406
000902559 9801_ $$aFullTexts